Bharti Hexacom Ltd
₹1716.20
+11.50 (0.67%)
Fri, 06 Nov 2026, 10:27 pm
Bharti Hexacom News
Bharti Hexacom appoints Akhil Garg and Amit Wadhwa
Bharti Hexacom appoints Akhil Garg as Non-Executive Director and Amit Wadhwa as CEO effective November 6, 2026. Soumen Ray and Marut Dilawari exit roles.
05 Nov 2026
companies
Bharti Hexacom Q2 net profit jumps 34% YoY
Bharti Hexacom reported a 34.4% YoY rise in Q2 net profit to ₹5.66 billion. Revenue grew 11.4% YoY to ₹25.82 billion, with EBITDA at ₹21.17 billion.
05 Nov 2026
companies
Bharti Hexacom RTA shifts office
Bharti Hexacom Limited announced the relocation of its Registrar and Share Transfer Agent, KFin Technologies, to a new Hyderabad address effective December 1, 2026.
04 Nov 2026
companies
Bharti Hexacom block trade of ₹55.46 crore on NSE
A block trade of approximately 401,338 shares of Bharti Hexacom was executed on the NSE at ₹1,381.80 per share, aggregating to ₹55.46 crore.
05 Oct 2026
equity-markets
Bharti Hexacom to host investor meets in HK
Bharti Hexacom Ltd will participate in the CITIC CLSA Investors' Forum and Bofa Asia Pacific Conference in Hong Kong on September 22-23, 2026.
17 Sept 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo